Skip to content

Cardiac Output Monitoring by Transpulmonary Thermodilution and Transthoracic Echocardiography in Critically Ill Patients

Cardiac Output Measurement in Critically Ill Patient in Sinus Rhythm: a Comparison Between Transpulmonary Thermodilution and Transthoracic Echocardiography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04637126
Acronym
TPTD-TTE-SR
Enrollment
36
Registered
2020-11-19
Start date
2020-03-06
Completion date
2021-02-10
Last updated
2021-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinus Rhythm

Keywords

Cardiac output monitoring, Transthoracic echocardiography, Transpulmonary thermodilution, Intensive care

Brief summary

Cardiac output monitoring is a key component for the diagnosis and management of critically ill patients. The two less invasive methods commonly used in intensive care are transthoracic echocardiography and transpulmonary thermodilution. The objective of this study is to compare accuracy and trending ability of CO measurement by TPTD and TTE in critically ill patients with sinus rhythm.

Detailed description

TTE is an easy noninvasive device now recommended as the first evaluation of the patient in circulatory failure but it present some limits due to poor echogenicity of patients, operator-dependent variability and cannot provide continuous hemodynamic data. TPTD is an invasive technique for CO monitoring recommended especially in shock not responsive to initial therapy. Few studies have evaluated the level of agreement of each method (TTE and TPTD) with the reference method (pulmonary artery catheter) but they have never been compared between them with strong statistical analysis in particular trending ability. It could be interesting to determine the level of concordance of these two methods of CO monitoring and trend ability by TPTD relative to TTE. The investigators hypothesize that CO-TPTD are concordant with those performed by TTE. Mechanically ventilated patients requiring hemodynamic assessment will be included. CO-TPTD will be measured via intermittent thermodilution. Blindly, a second investigator will use standard-view TTE to estimate CO-TTE as the product of stroke volume and the heart rate obtained during the measurement the blood flow velocity (using a Doppler technique) at the left ventricular outflow tract. A second measurement will be done with the two devices after a fluid challenge when patient requires it to compare trending ability.

Interventions

OTHERCardiac output measurement by transpulmonary thermodilution and transthoracic echocardiography

Cardiac output is measured for all patients with transpulmonary thermodilution TPTD and transthoracic echocardiography TTE according to the recommendations

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* mechanically ventilated and sedated patients * with sinus rhythm * hospitalized in Intensive Care Unit * fitted with an hemodynamic monitoring by thermodilution technique due to hemodynamic failure

Exclusion criteria

* age under 18 * arrhythmia * severe aortic regurgitation or stenosis * intracardiac shunt * poor echogenicity * tamponade * major subject to a legal protection regim.

Design outcomes

Primary

MeasureTime frameDescription
bias between cardiac output measurement by TPTD and by TTEDay 0bias between cardiac output measurement by transthoracic echocardiography and transpulmonary thermodilution

Secondary

MeasureTime frameDescription
percentage error between cardiac output measurement by transthoracic echocardiography and transpulmonary thermodilutionDay 0percentage error between cardiac output measurement by transthoracic echocardiography and transpulmonary thermodilution
percentage error between the value of Cardiac Output measured with TTE (transthoracic echocardiography) and the value of Cardiac Output measured withTPTD (transpulmonary thermodilution) after a fluid challenge.15 minutes after inclusionpercentage error between the value of Cardiac Output measured with TTE and the value of Cardiac Output measured withTPTD after a fluid challenge.
The ability of TPTD (transpulmonary thermodilution) to track Cardiac Output as measured with TTE (transthoracic echocardiography)15 minutes after inclusionThe ability of TPTD to track Cardiac Output as measured with TTE.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026